Description

Ethyl 4-(4-Methoxybenzylamino)-6-Chloropyridine-3-Carboxylate is a high-purity, advanced pharmaceutical intermediate with a defined molecular structure. This compound is critical for research and development in medicinal chemistry, serving as a key building block for synthesizing novel active pharmaceutical ingredients (APIs). It is primarily needed by pharmaceutical R&D laboratories, fine chemical manufacturers, and academic institutions focused on developing new therapeutic agents, particularly in areas requiring complex heterocyclic scaffolds.

Application

• Pharmaceutical Intermediate: A crucial precursor in the multi-step synthesis of potential drug candidates, especially those targeting specific enzyme pathways.
• Medicinal Chemistry Research: Used as a scaffold for structure-activity relationship (SAR) studies to optimize potency and selectivity of new chemical entities.
• Fine Chemical Synthesis: Employed in the production of complex, high-value specialty chemicals for agrochemical or material science applications.
• Contract Research & Development (CRO/CMO): Supplied to organizations specializing in custom synthesis and process development for client projects.
• Academic Research: Utilized in university and institutional labs for investigating new synthetic methodologies and heterocyclic chemistry.
• API Development: Integrated into the synthesis route during the early-stage development of new Active Pharmaceutical Ingredients.

Basic Information

Product Name	Ethyl 4-(4-Methoxybenzylamino)-6-Chloropyridine-3-Carboxylate
CAS No.	1391740-89-8
Molecular Formula	C16H17ClN2O3
Molecular Weight	320.77 g/mol
Synonyms	Ethyl 4-[(4-methoxyphenyl)methylamino]-6-chloropyridine-3-carboxylate; 6-Chloro-4-[(4-methoxybenzyl)amino]nicotinic acid ethyl ester; 4-(4-Methoxybenzylamino)-6-chloro-nicotinic acid ethyl ester; Ethyl 6-chloro-4-((4-methoxybenzyl)amino)nicotinate; 1391740-89-8; 6-Chloro-4-[(4-methoxybenzyl)amino]-3-pyridinecarboxylic acid ethyl ester
EINECS	Contact for details

Quality Control

Our Ethyl 4-(4-Methoxybenzylamino)-6-Chloropyridine-3-Carboxylate is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods (NMR, IR, MS), to ensure it meets the high standards required for pharmaceutical R&D. A comprehensive Certificate of Analysis (COA) detailing all specifications is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). Keep away from incompatible materials. For long-term storage, consider inert atmosphere conditions to maintain optimal stability.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.